These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34125930)

  • 41. Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis.
    Xing Z; Tang L; Chen C; Huang J; Zhu Z; Hu X
    Braz J Cardiovasc Surg; 2017; 32(5):417-422. PubMed ID: 29211223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spanish Implantable Cardioverter-defibrillator Registry. Ninth official report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012).
    Alzueta J; Fernández JM
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):881-93. PubMed ID: 24773996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospitalizations for heart failure and mortality risk during the evolving coronavirus disease 2019 pandemic - the wave may break but a dangerous undertow persists.
    Wagner JR; Ambrosy AP
    Eur J Heart Fail; 2020 Dec; 22(12):2225-2227. PubMed ID: 33125819
    [No Abstract]   [Full Text] [Related]  

  • 45. Operation of the First Regional Milk Bank in Poland During a SARS-CoV-2 (COVID-19) Pandemic.
    Sinkiewicz-Darol E; Bernatowicz-Łojko U
    J Hum Lact; 2020 Nov; 36(4):626-627. PubMed ID: 32960122
    [No Abstract]   [Full Text] [Related]  

  • 46. Implantable Cardioverter-Defibrillators Have Stood the Test of Time!
    Al-Khatib SM; Kusumoto FM
    Circulation; 2019 Nov; 140(19):1540-1542. PubMed ID: 31476898
    [No Abstract]   [Full Text] [Related]  

  • 47. Implantable cardioverter defibrillator therapy for patients with life-threatening ventricular arrhythmias and severe heart failure.
    Mecca A; Barakat T; Guo H; Olshansky B
    Am J Cardiol; 2000 Oct; 86(8):875-7. PubMed ID: 11024405
    [No Abstract]   [Full Text] [Related]  

  • 48. Impact of Meteorological Conditions on the Dynamics of the COVID-19 Pandemic in Poland.
    Bochenek B; Jankowski M; Gruszczynska M; Nykiel G; Gruszczynski M; Jaczewski A; Ziemianski M; Pyrc R; Figurski M; Pinkas J
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33918658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
    Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
    Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disparities in heart failure care: now is the time to focus on health care delivery.
    Pinney SP
    J Am Coll Cardiol; 2014 Aug; 64(8):808-10. PubMed ID: 25145525
    [No Abstract]   [Full Text] [Related]  

  • 53. Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry".
    Schrage B; Linde C; Braunschweig F; Savarese G
    Circulation; 2020 Mar; 141(11):e648-e649. PubMed ID: 32176544
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of the course of SARS-CoV-2 infection in left ventricular assist device recipients implanted before and during COVID-19 pandemic.
    Wiśniowska-Śmiałek S; Rubiś P; Wasilewski G; Górkiewicz-Kot I; Kaleta M; Vashchelina L; Milaniak I; Dziewięcka E; Krupa-Hubner F; Tomsia P; Drwiła R; Hymczak H; Sobczyk D; Kapelak B; Wierzbicki K
    Cardiol J; 2023; 30(4):668-670. PubMed ID: 37401418
    [No Abstract]   [Full Text] [Related]  

  • 55. Important Parameters for Implantable Cardioverter Defibrillator Selection.
    Zungsontiporn N; Loguidice M; Daniels J
    Card Electrophysiol Clin; 2018 Mar; 10(1):145-152. PubMed ID: 29428136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.
    Gold MR; Aasbo JD; El-Chami MF; Niebauer M; Herre J; Prutkin JM; Knight BP; Kutalek S; Hsu K; Weiss R; Bass E; Husby M; Stivland TM; Burke MC
    Heart Rhythm; 2017 Oct; 14(10):1456-1463. PubMed ID: 28502872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.
    Biffi M; Iori M; De Maria E; Bolognesi MG; Placci A; Calvi V; Allocca G; Ammendola E; Carinci V; Boggian G; Saporito D; Grassini D; Giacopelli D; Statuto G; Ziacchi M
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):846-853. PubMed ID: 32064713
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.
    Fonarow GC; Ziaeian B
    J Am Coll Cardiol; 2016 Mar; 67(9):1070-1073. PubMed ID: 26940928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.